Private Market View

Neurava

Baltimore, MD · Founded 2019 · Privately Held (backing)

Last price · $/share
—
Implied valuation
$20.1M
Total raised
$6.5M
Last round
Seed Round
Oct 2025

Key facts

  • Neurava’s last known valuation is $20.1M (Oct 2025).
  • It has raised $6.5M across 1 recorded rounds; the latest was Seed Round ($1.6M) in Oct 2025.
  • Notable investors include MassChallenge, MedTech Innovator, Elevate Ventures, Ecphora Capital, Sugati Ventures — 20 tracked in total.
  • 1 investment vehicle was formed to buy Neurava shares in the last 12 months, reporting $185K sold to 3 investors, per SEC Form D filings.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 20 names
  • ·Watchlist + deal alerts for Neurava
Create free account
No card required

Funding rounds

1 rounds
Oct 2025Seed Round$1.6MSEC filing▮
Full funding history →

Secondary demand: investment vehicles

from SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy Neurava shares, reporting $185K sold to 3 investors. Most recent filing Oct 2025. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle →
Companies with the most vehicle activity →

About Neurava

Developer of an artificial intelligence-powered wearable platform designed to track physiological indicators associated with sudden unexpected death in epilepsy and support management of epilepsy-related risks. The company offers multi-parameter neurological and cardiovascular monitoring, data synchronization, and timely notifications, enabling individuals with early and drug-resistant epilepsy, caregivers, and clinicians to take preventative measures, identify high-risk patterns, and support daily care.

Sector
Healthcare
HQ
Baltimore, MD, United States
Founded
2019
Employees
3
Ownership
Privately Held (backing)
PA Mark — not yet priced

Neurava doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Neurava shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Neurava in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.